title: New and different approaches needed for the design and execution of Alzheimer's clinical trials.
authors.forename: Maria C
authors.initials: MC
authors.lastname: Carrillo
authors.forename: Bruno
authors.initials: B
authors.lastname: Vellas
mesh_terms: D000544:Alzheimer Disease / Q000517:prevention & control*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D006801:Humans; D015337:Multicenter Studies as Topic / Q000379:methods*; D018697:Nootropic Agents / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic / Q000379:methods*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018697:Nootropic Agents; C550616:solanezumab; C545458:bapineuzumab